The store will not work correctly when cookies are disabled.
5-Pyridin-4-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA309310
PubChem CID: 10060534
Max Phase: Preclinical
Molecular Formula: C16H13N3
Molecular Weight: 247.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C1=C(c2ccncc2)N2CCN=C2c2ccccc21
Standard InChI: InChI=1S/C16H13N3/c1-2-4-14-13(3-1)11-15(12-5-7-17-8-6-12)19-10-9-18-16(14)19/h1-8,11H,9-10H2
Standard InChI Key: MFVYQGMRRKNURM-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
3.2125 -5.3875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7000 -5.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2417 -4.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -4.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1792 -5.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7000 -6.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1917 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7792 -4.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8417 -3.9792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7292 -5.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7292 -6.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6500 -5.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6875 -4.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8167 -4.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3292 -3.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2792 -4.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8042 -3.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1375 -5.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1542 -4.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 15 1 0
10 1 1 0
11 10 1 0
12 5 1 0
13 7 1 0
14 16 1 0
15 17 2 0
16 8 2 0
17 8 1 0
18 12 2 0
19 13 2 0
11 6 1 0
7 5 2 0
9 14 2 0
18 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 247.30 | Molecular Weight (Monoisotopic): 247.1109 | AlogP: 2.66 | #Rotatable Bonds: 1 |
Polar Surface Area: 28.49 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.06 | CX LogP: 1.84 | CX LogD: 1.68 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.77 | Np Likeness Score: -0.36 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |